CannabisNewsBreaks

WednesdayDec 29, 2021 1:05 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Approval from Independent Review Board for DehydraTECH-CBD Human Clinical Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has received Independent Review Board ("IRB") approval for its planned DehydraTECH-CBD human hypertension study HYPER-H21-4; the approval was received earlier than anticipated. The study is designed to "de-risk" outcomes prior to the company’s planned entry into regulatory pathways for the use of DehydraTECH-CBD to treat hypertension and perhaps other forms of cardiovascular disease. The six-week study, which is entirely funded through the existing cash resources, is planned to include 60 volunteers, aged 45 to 70, using three 150 mg doses of DehydraTECH-CBD daily for the duration of the study. Dosing…

Continue Reading

MondayDec 27, 2021 1:56 pm

CannabisNewsBreaks – RYAH Group Inc.’s (CSE: RYAH) Smart Dry Herb Inhaler Providing Consistent, Predictable Results

RYAH Group (CSE: RYAH) develops innovative IoT products that capture powerful data insights and is on a mission to transform patient care using big data and AI to reshape the understanding and uses of plant-based medicines. The company’s devices and data are being used by a rapidly growing number of participants in plant-based clinical trials around the world, including clinical research into the relationship between medical cannabis consumption and cancer treatment, which is in the very early stages. “Two key constraints that have limited the viability of cannabis studies within an oncological setting are the highly variable nature of the…

Continue Reading

ThursdayDec 23, 2021 1:06 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Building World-Class House of Brands

Flora Growth Corp. (NASDAQ: FLGC) recently signed a licensing agreement with Tonino Lamborghini that marked Flora Growth’s entry into the cannabis beverages market. Under the terms of the partnership, FLGC will produce and distribute Tonino Lamborghini-branded cannabis beverages across North America and Colombia. The product line, which will be produced in Florida for initial sale in U.S. states where cannabidiol (“CBD”) ingestibles are legal, will contain CBD and other premium cannabinoids, including cannabigerol (“CBG”). Tonino Lamborghini is a luxury brand operating in the high-end designer products, hotel, beverage and real estate segments. “We are excited to partner with such a…

Continue Reading

WednesdayDec 22, 2021 11:46 am

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Partners with Avicanna to Launch New Derma-Cosmetic Brand

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, is working with Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) to unveil a new THC-free, CBD derma-cosmetic brand. The first known CBD skincare line to be clinically tested and commercialized across four international markets, Pura H&W will include seven SKUs of proprietary products. The products are formulated using a combination of purified CBD and other synergistic botanical ingredients designed to naturally regulate and nourish the skin. The Pura H&W product line was developed by Avicanna and specific products have undergone clinical trials.…

Continue Reading

TuesdayDec 21, 2021 2:52 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Pursuing Regulatory Approvals for DehydraTECH(TM), Entry into Different Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX) is embarking on new programs as well as extending ongoing ones as it pursues regulatory approvals and entry into different market sectors. In January 2022, the company expects to report blood pressure findings from its third human hypertension study, HYPER-H21-3, building on the successes of the first two human studies that evidenced effective, sustained and safe blood pressure reduction with DehydraTECH-CBD. The company will also be expecting approvals for the protocols around its fourth hypertension study, HYPER-H21-4, which is just one of the many planned studies slated for 2022. “Others include HOR-A22-1, a pharmacokinetic study…

Continue Reading

MondayDec 20, 2021 12:30 pm

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Ranks in List of Top 101 Canadian F&B Startups and Companies

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has been named one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada. The ranking recognizes the company’s leadership position within both the food & beverage and cannabis product categories. Companies listed in the rankings include cutting-edge startups and established brands alike, but each company is known for innovation within their sector, exceptional growth and societal impact. BevCanna was within the group of selected companies that exhibited exceptional performance. In addition, BVNNF was also included within…

Continue Reading

FridayDec 17, 2021 2:58 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Focused on Florida Ahead of ‘Massive Medical Marijuana Boom’

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis sector operator, is off to a strong start in building its high-quality flower resource for product inventory at dispensaries throughout Florida. The company has been working to launch growing operations at its Apopka, Florida-based cultivation location, adding 19,200 square feet of production expected to deliver $30 million in annual revenues. The pods were approved by the state health department’s Office of Medical Marijuana Use (“OMMU”) with licensing granted just before Halloween, with five already in use for plant growth at that time with the remainder fast-tracked for output.…

Continue Reading

ThursdayDec 16, 2021 10:54 am

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) to Collaborate with OMNI Medical Services for Cannabis Study in Treatment of COVID-19

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has announced plans for a U.S. clinical study focused on treatment COVID-19. RYAH will be partnering with OMNI Medical Services to perform the U.S.-based clinical study evaluating patients using inhalation of medical cannabis to both treat and prevent the coronavirus. The study, which will run for five years, will involve the use of RYAH’s Smart Inhaler devices and will involve up to 11,000 of OMNI’s patients across the country. Phase 2 of the…

Continue Reading

TuesdayDec 14, 2021 1:26 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Study Results Expected to Demonstrate DehydraTECH-CBD’s Effectiveness Against Hypertension

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its human clinical study HYPER-H21-3 is expected to complete all dosing and sample collection this week. The study, undertaken to examine the effects of DehydraTECH-CBD upon acute pulmonary hypertension, used a blinded design with administration of a single 300mg dose of a specific DehydraTECH 2.0 CBD formulation compared to placebo in a target group of sixteen enrolled volunteers. Subject to pending analysis of samples collected from the study, blood pressure results are expected to be reported soon. Exposure to acute reductions in oxygen tension (i.e.,…

Continue Reading

TuesdayDec 14, 2021 12:58 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Year-End Review Webinar

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, will provide an overview on the company’s performance at a year-end review; the online event is scheduled for today, Dec. 14, 2021, at 4:30 p.m. ET. Flora Growth CEO Luis Merchan will host the webinar, which will include an update on the company’s 2021 operational performance as well as commentary on its 2022 revenue guidance of $35 to $45 million; the event will also include a Q&A session. Anyone interested in attending is invited to participate. Questions can be submitted in advance for the…

Continue Reading